APA aipamena

Hanif, A., Wang, E. S., Thompson, J. E., Baron, J. I., Walsh, M. D., & Griffiths, E. A. (2017). Combining Blinatumomab with Targeted Therapy for BCR-ABL Mutant Relapsed/ Refractory Acute Lymphoblastic leukemia. Leuk Lymphoma.

Chicago Style aipamena

Hanif, Ahmad, Eunice S. Wang, James E. Thompson, Jeffrey I. Baron, Mark D. Walsh, and Elizabeth A. Griffiths. "Combining Blinatumomab With Targeted Therapy for BCR-ABL Mutant Relapsed/ Refractory Acute Lymphoblastic Leukemia." Leuk Lymphoma 2017.

MLA aipamena

Hanif, Ahmad, et al. "Combining Blinatumomab With Targeted Therapy for BCR-ABL Mutant Relapsed/ Refractory Acute Lymphoblastic Leukemia." Leuk Lymphoma 2017.